Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 15 November 2021
Sec. Thrombosis and Haemostasis
Volume 8 - 2021 | https://doi.org/10.3389/fcvm.2021.800151
This article is part of the Research Topic Inflammation/Infection and Fibrin(ogen) View all 4 articles

Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis

This article is a correction to:

  1. γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis

    1. Read original article
\nAna Catarina Pronto-Laborinho&#x;Ana Catarina Pronto-Laborinho1†Catarina S. Lopes&#x;Catarina S. Lopes1†Vasco A. ConceioVasco A. Conceição1Marta GromichoMarta Gromicho1Nuno C. SantosNuno C. Santos1Mamede de Carvalho,Mamede de Carvalho1,2Filomena A. Carvalho Filomena A. Carvalho1*
  • 1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
  • 2Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte (CHULN), Lisbon, Portugal

A Corrigendum on
γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis

by Pronto-Laborinho, A. C., Lopes, C. S., Conceição, V. A., Gromicho, M., Santos, N. C., de Carvalho, M., and Carvalho, F. A. (2021). Front. Cardiovasc. Med. 8:715842. doi: 10.3389/fcvm.2021.715842

The Funding statement had an error in the reference of one project. Instead of PTDC/EMD-TLM/4644/2021, it should be PTDC/EMD-TLM/7289/2020.

Funding

This work was supported by UID/BIM/50005/2019 and PTDC/EMD-TLM/7289/2020, a project funded by Fundação para a Ciência e a Tecnologia - Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES), through Fundos do Orçamento de Estado (Portugal). CSL also acknowledges FCT-MCTES fellowship PD/BD/135045/2017.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: amyotrophic lateral sclerosis, prognosis, respiratory function, survival, gamma′ fibrinogen

Citation: Pronto-Laborinho AC, Lopes CS, Conceição VA, Gromicho M, Santos NC, de Carvalho M and Carvalho FA (2021) Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis. Front. Cardiovasc. Med. 8:800151. doi: 10.3389/fcvm.2021.800151

Received: 22 October 2021; Accepted: 25 October 2021;
Published: 15 November 2021.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Pronto-Laborinho, Lopes, Conceição, Gromicho, Santos, de Carvalho and Carvalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Filomena A. Carvalho, filomenacarvalho@medicina.ulisboa.pt

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.